The Fund For Blood And Cancer Research Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 337,720 | 79,092 | 258,628 | 245.0 | 0% |
| 2012 | 128,996 | 232,173 | −103,177 | 82.2 | 0% |
| 2013 | 182,836 | 355,633 | −172,797 | 50.2 | 0% |
| 2014 | 136,119 | 245,819 | −109,700 | 67.9 | 0% |
| 2015 | 108,816 | 59,955 | 48,861 | 278.1 | 0% |
| 2016 | 321,851 | 55,153 | 266,698 | 368.6 | 0% |
| 2017 | 133,796 | 140,564 | −6,768 | 150.2 | 0% |
| 2018 | 284,245 | 119,579 | 164,666 | 182.8 | 0% |
| 2019 | 156,354 | 46,953 | 109,401 | 523.8 | 0% |
| 2020 | 83,256 | 36,706 | 46,550 | 706.9 | 0% |
| 2021 | 112,918 | 35,191 | 77,727 | 786.3 | 0% |
| 2022 | 99,757 | 47,586 | 52,171 | 536.6 | 0% |
| 2023 | 59,433 | 283,350 | −223,917 | 85.8 | 0% |
In its most recent public year (2023), this organization spent $223,917 more than it brought in. Its reserves stood at about 85.8 months of spending, down from 245 in 2011. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
The Fund For Blood And Cancer Research Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works